PDL's mAb technology finds right timing.
Fletcher
L
L
D000818:Animals; D000906:Antibodies / Q000097:blood; D000911:Antibodies, Monoclonal / Q000097:blood / Q000191:economics / Q000627:therapeutic use*; D001709:Biotechnology / Q000191:economics / Q000379:methods* / Q000639:trends; D006801:Humans; D051379:Mice / Q000276:immunology; D019076:Transgenes; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards
D000906:Antibodies; D000911:Antibodies, Monoclonal